Bin Zhao

2.1k total citations
97 papers, 1.5k citations indexed

About

Bin Zhao is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bin Zhao has authored 97 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 21 papers in Surgery and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bin Zhao's work include Cholesterol and Lipid Metabolism (11 papers), Pharmacovigilance and Adverse Drug Reactions (10 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Bin Zhao is often cited by papers focused on Cholesterol and Lipid Metabolism (11 papers), Pharmacovigilance and Adverse Drug Reactions (10 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Bin Zhao collaborates with scholars based in China, United States and Germany. Bin Zhao's co-authors include Shobha Ghosh, Jingmei Song, Jinghua Bie, Richard W. St. Clair, Yali Xu, Ramesh Natarajan, Yu Song, Woon N. Chow, Lawrence L. Rudel and Qianqian Fan and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Bin Zhao

91 papers receiving 1.5k citations

Peers

Bin Zhao
Jianyu Hao China
Kenji Takemoto Japan
Miaomiao Wang China
Kiyoko Oshima United States
Moe H. Kyaw Hong Kong
Jacky Vonderscher Switzerland
Hülya Yılmaz Türkiye
Lei Gao China
Jianyu Hao China
Bin Zhao
Citations per year, relative to Bin Zhao Bin Zhao (= 1×) peers Jianyu Hao

Countries citing papers authored by Bin Zhao

Since Specialization
Citations

This map shows the geographic impact of Bin Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Zhao more than expected).

Fields of papers citing papers by Bin Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bin Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Zhao. The network helps show where Bin Zhao may publish in the future.

Co-authorship network of co-authors of Bin Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Bin Zhao. A scholar is included among the top collaborators of Bin Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bin Zhao. Bin Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Xie, Hao, Qiang Xu, Bin Zhao, & Wenming Wu. (2025). Drug-associated pancreatic cancer: insights from real-world pharmacovigilance and network pharmacology. Expert Opinion on Drug Safety. 1–11. 1 indexed citations
3.
Wang, Zixi, Lisha Li, Yingyang Xu, et al.. (2024). Anaphylactic risk associated with iodinated and gadolinium-based contrast media. Expert Opinion on Drug Safety. 25(1). 167–173. 1 indexed citations
4.
5.
6.
Zhang, Tingting, Bin Zhao, Chuanhao Tang, et al.. (2023). Pneumatosis intestinalis post steroid use in a patient with immune-related adverse events: Case report, literature review and FAERS analysis. Frontiers in Pharmacology. 14. 1133551–1133551. 4 indexed citations
7.
Wang, Li & Bin Zhao. (2023). Janus kinase inhibitor—Tofacitinib associated with pemphigus: an analysis of the FDA adverse event reporting system data. Expert Opinion on Drug Safety. 22(12). 1317–1320. 4 indexed citations
8.
Wang, Jing, Xuedong Yin, Linlin Yu, et al.. (2023). Delayed cutaneous hypersensitivity reactions following the use of infliximab or adalimumab in patients with coronavirus disease 2019. Journal of Medical Virology. 95(2). e28518–e28518. 2 indexed citations
9.
Zhao, Bin, et al.. (2022). Does eltrombopag lead to thrombotic events? A pharmacovigilance study of theFDAadverse event reporting system. Journal of Clinical Pharmacy and Therapeutics. 47(10). 1556–1562. 7 indexed citations
10.
Chen, Gang, et al.. (2022). Acute kidney injury following SGLT2 inhibitors among diabetic patients: a pharmacovigilance study. International Urology and Nephrology. 54(11). 2949–2957. 9 indexed citations
11.
Fan, Qianqian, et al.. (2021). Guillain–Barré syndrome in patients treated with immune checkpoint inhibitors. Journal of Neurology. 268(6). 2169–2174. 25 indexed citations
12.
Li, Lisha, et al.. (2021). Anaphylactic risk related to omalizumab, benralizumab, reslizumab, mepolizumab, and dupilumab. Clinical and Translational Allergy. 11(4). e12038–e12038. 38 indexed citations
13.
Fan, Qianqian, Jie Ma, Bo Zhang, et al.. (2020). Assessment of acute kidney injury related to small-molecule protein kinase inhibitors using the FDA adverse event reporting system. Cancer Chemotherapy and Pharmacology. 86(5). 655–662. 6 indexed citations
14.
Zhao, Bin, et al.. (2020). Do sodium–glucose cotransporter 2 inhibitors lead to fracture risk? A pharmacovigilance real‐world study. Journal of Diabetes Investigation. 12(8). 1400–1407. 15 indexed citations
15.
16.
17.
Wang, Changjun, Chang Chen, Yan Lin, et al.. (2020). Validation of CTS5 model in large-scale breast cancer population and the impact of menopausal and HER2 status on its prognostic value. Scientific Reports. 10(1). 4660–4660. 12 indexed citations
18.
Song, Yu, Yali Xu, Yan Lin, Bin Zhao, & Qiang Sun. (2020). Fractures due to Aromatase Inhibitor Therapy for Breast Cancer: A Real-World Analysis of FAERS Data in the Past 15 Years. Oncology Research and Treatment. 43(3). 96–102. 25 indexed citations
19.
Li, Zijian, et al.. (2018). Nutrition support in hospitalized cancer patients with malnutrition in China.. PubMed. 27(6). 1216–1224. 18 indexed citations
20.
Diraviyam, Thirumalai, et al.. (2014). Effect of Chicken Egg Yolk Antibodies (IgY) against Diarrhea in Domesticated Animals: A Systematic Review and Meta-Analysis. PLoS ONE. 9(5). e97716–e97716. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jianyu Hao Breakdown of academic impact, for papers by Kenji Takemoto Breakdown of academic impact, for papers by Miaomiao Wang Breakdown of academic impact, for papers by Kiyoko Oshima Breakdown of academic impact, for papers by Moe H. Kyaw Breakdown of academic impact, for papers by Jacky Vonderscher Breakdown of academic impact, for papers by Hülya Yılmaz Breakdown of academic impact, for papers by Lei Gao
Rankless by CCL
2026